Diversity and inclusivity in Australian dementia prevention research: A mixed methods review

IF 7.4 Q1 CLINICAL NEUROLOGY
Olivia E. Giameos, Maddison L. Mellow, Diana Karamacoska, Aaron Davis, Paul A Gardiner, Eddy Roccati, Kaarin J. Anstey, Nicolas Cherbuin, Jessica M. Adsett, Nikki-Anne Wilson, Kylie Radford, Louise Lavrencic, Perminder S. Sachdev, Simone Reppermund, Suraj Samtani, Annabel P. Matison, Zara A. Page, Philip J. Batterham, Sophie C. Andrews, Alex Bahar-Fuchs, Michelle K. Lupton, Andrew Pipingas, Adrienne Withall, Belinda M. Brown, Helen Macpherson, Hannah A. D. Keage, Britt Burton, James C. Vickers, David W Dunstan, Ashleigh E. Smith
{"title":"Diversity and inclusivity in Australian dementia prevention research: A mixed methods review","authors":"Olivia E. Giameos,&nbsp;Maddison L. Mellow,&nbsp;Diana Karamacoska,&nbsp;Aaron Davis,&nbsp;Paul A Gardiner,&nbsp;Eddy Roccati,&nbsp;Kaarin J. Anstey,&nbsp;Nicolas Cherbuin,&nbsp;Jessica M. Adsett,&nbsp;Nikki-Anne Wilson,&nbsp;Kylie Radford,&nbsp;Louise Lavrencic,&nbsp;Perminder S. Sachdev,&nbsp;Simone Reppermund,&nbsp;Suraj Samtani,&nbsp;Annabel P. Matison,&nbsp;Zara A. Page,&nbsp;Philip J. Batterham,&nbsp;Sophie C. Andrews,&nbsp;Alex Bahar-Fuchs,&nbsp;Michelle K. Lupton,&nbsp;Andrew Pipingas,&nbsp;Adrienne Withall,&nbsp;Belinda M. Brown,&nbsp;Helen Macpherson,&nbsp;Hannah A. D. Keage,&nbsp;Britt Burton,&nbsp;James C. Vickers,&nbsp;David W Dunstan,&nbsp;Ashleigh E. Smith","doi":"10.1002/trc2.70296","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <p>Minoritized communities are disproportionately impacted by modifiable dementia risk factors but are underrepresented in dementia research globally. In Australia, the number of dementia prevention cohort and intervention studies has rapidly increased in the past two decades, yet the representation of minoritized groups has not been synthesized. The aims of this mixed-methods review were to summarize the demographic characteristics of participants involved in Australian dementia prevention-focused cohort and intervention studies. A systematic search of published literature, funded grant outcomes, and clinical trial registrations was conducted in October 2023 and updated in February 2025 to identify any Australia-based cohort or intervention studies which focused on dementia prevention. Data custodians of eligible studies were contacted and invited to submit de-identified participant-level data for these studies. The demographic characteristics of participants involved in published manuscripts and submitted participant-level data were synthesized. These data were then presented to 23 Australian dementia prevention researchers during a 2-h workshop in March 2025. Using co-creation methodologies, the workshop aimed to generate consensus-based recommendations for governments, institutions, and individual researchers to improve inclusivity and representativeness in future dementia prevention research. Twenty-eight published dementia prevention studies were summarized alongside fourteen studies for which de-identified participant-level data were submitted. Compared to the modern Australian population, participants enrolled in dementia prevention studies have been predominantly female, highly educated, and less diverse in terms of culture, language, ethnicity and gender. Thirty-seven recommendations were generated by Australian researchers and ranked by importance, providing actionable changes for government and institutional policy and researcher practice. This review identified that participants enrolled in Australian dementia prevention research studies do not accurately represent those most at risk for dementia in the general population. Changes to recruitment and engagement practices and policies are recommended to improve the representativeness and inclusivity of Australian dementia prevention research.</p>\n </section>\n </div>","PeriodicalId":53225,"journal":{"name":"Alzheimer''s and Dementia: Translational Research and Clinical Interventions","volume":"12 3","pages":""},"PeriodicalIF":7.4000,"publicationDate":"2026-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13380669/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Translational Research and Clinical Interventions","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/trc2.70296","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Minoritized communities are disproportionately impacted by modifiable dementia risk factors but are underrepresented in dementia research globally. In Australia, the number of dementia prevention cohort and intervention studies has rapidly increased in the past two decades, yet the representation of minoritized groups has not been synthesized. The aims of this mixed-methods review were to summarize the demographic characteristics of participants involved in Australian dementia prevention-focused cohort and intervention studies. A systematic search of published literature, funded grant outcomes, and clinical trial registrations was conducted in October 2023 and updated in February 2025 to identify any Australia-based cohort or intervention studies which focused on dementia prevention. Data custodians of eligible studies were contacted and invited to submit de-identified participant-level data for these studies. The demographic characteristics of participants involved in published manuscripts and submitted participant-level data were synthesized. These data were then presented to 23 Australian dementia prevention researchers during a 2-h workshop in March 2025. Using co-creation methodologies, the workshop aimed to generate consensus-based recommendations for governments, institutions, and individual researchers to improve inclusivity and representativeness in future dementia prevention research. Twenty-eight published dementia prevention studies were summarized alongside fourteen studies for which de-identified participant-level data were submitted. Compared to the modern Australian population, participants enrolled in dementia prevention studies have been predominantly female, highly educated, and less diverse in terms of culture, language, ethnicity and gender. Thirty-seven recommendations were generated by Australian researchers and ranked by importance, providing actionable changes for government and institutional policy and researcher practice. This review identified that participants enrolled in Australian dementia prevention research studies do not accurately represent those most at risk for dementia in the general population. Changes to recruitment and engagement practices and policies are recommended to improve the representativeness and inclusivity of Australian dementia prevention research.

Abstract Image

澳大利亚痴呆症预防研究的多样性和包容性:混合方法综述。
少数民族社区受到可改变的痴呆症风险因素的影响不成比例,但在全球痴呆症研究中代表性不足。在澳大利亚,痴呆预防队列和干预研究的数量在过去二十年中迅速增加,但少数群体的代表性尚未得到综合。这项混合方法综述的目的是总结参与澳大利亚痴呆症预防队列和干预研究的参与者的人口统计学特征。研究人员于2023年10月对已发表的文献、资助结果和临床试验注册进行了系统检索,并于2025年2月进行了更新,以确定任何以澳大利亚为基础的以痴呆症预防为重点的队列或干预研究。我们联系了符合条件的研究的数据保管人,并邀请他们提交这些研究的去识别参与者水平的数据。对发表的稿件和提交的参与者水平数据中涉及的参与者的人口统计学特征进行综合。这些数据随后在2025年3月为期2小时的研讨会上提交给23名澳大利亚痴呆症预防研究人员。研讨会采用共同创造的方法,旨在为政府、机构和个人研究人员提供基于共识的建议,以提高未来痴呆症预防研究的包容性和代表性。我们总结了28项已发表的痴呆症预防研究,以及14项提交了未识别参与者数据的研究。与现代澳大利亚人口相比,参加痴呆症预防研究的参与者主要是受过高等教育的女性,在文化、语言、种族和性别方面的多样性较低。澳大利亚研究人员提出了37项建议,并按重要性排序,为政府和机构政策以及研究人员的实践提供了可行的改变。本综述发现,参加澳大利亚痴呆症预防研究的参与者并不能准确地代表一般人群中患痴呆症风险最高的人群。建议改变招聘和参与实践和政策,以提高澳大利亚痴呆症预防研究的代表性和包容性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.10
自引率
2.10%
发文量
134
审稿时长
10 weeks
期刊介绍: Alzheimer''s & Dementia: Translational Research & Clinical Interventions (TRCI) is a peer-reviewed, open access,journal from the Alzheimer''s Association®. The journal seeks to bridge the full scope of explorations between basic research on drug discovery and clinical studies, validating putative therapies for aging-related chronic brain conditions that affect cognition, motor functions, and other behavioral or clinical symptoms associated with all forms dementia and Alzheimer''s disease. The journal will publish findings from diverse domains of research and disciplines to accelerate the conversion of abstract facts into practical knowledge: specifically, to translate what is learned at the bench into bedside applications. The journal seeks to publish articles that go beyond a singular emphasis on either basic drug discovery research or clinical research. Rather, an important theme of articles will be the linkages between and among the various discrete steps in the complex continuum of therapy development. For rapid communication among a multidisciplinary research audience involving the range of therapeutic interventions, TRCI will consider only original contributions that include feature length research articles, systematic reviews, meta-analyses, brief reports, narrative reviews, commentaries, letters, perspectives, and research news that would advance wide range of interventions to ameliorate symptoms or alter the progression of chronic neurocognitive disorders such as dementia and Alzheimer''s disease. The journal will publish on topics related to medicine, geriatrics, neuroscience, neurophysiology, neurology, psychiatry, clinical psychology, bioinformatics, pharmaco-genetics, regulatory issues, health economics, pharmacoeconomics, and public health policy as these apply to preclinical and clinical research on therapeutics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书